Tenax Therapeutics, Inc.

The momentum for this stock is not very good. Tradey thinks it is not wise to invest in Tenax Therapeutics, Inc..
Log in to see more information.
Tenax Therapeutics, Inc. is a pharmaceutical company, which focuses on identifying, developing, and...

News

Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated by Analysts at StockNews.com
Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated by Analysts at StockNews.com

Ticker Report StockNews.com initiated coverage on shares of Tenax Therapeutics (NASDAQ:TENX - Free Report) in a research note published on Tuesday morning. The brokerage issued a sell rating on the specialty...\n more…

Tenax Therapeutics (NASDAQ:TENX) Share Price Passes Above 200 Day Moving Average of $3.67
Tenax Therapeutics (NASDAQ:TENX) Share Price Passes Above 200 Day Moving Average of $3.67

Zolmax Tenax Therapeutics, Inc. (NASDAQ:TENX - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of...\n more…

Tenax Therapeutics (NASDAQ:TENX) Research Coverage Started at StockNews.com
Tenax Therapeutics (NASDAQ:TENX) Research Coverage Started at StockNews.com

Zolmax Equities researchers at StockNews.com began coverage on shares of Tenax Therapeutics (NASDAQ:TENX - Get Free Report) in a research note issued to investors on Tuesday. The brokerage set a "sell...\n more…

Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated by Analysts at StockNews.com
Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated by Analysts at StockNews.com

Zolmax StockNews.com began coverage on shares of Tenax Therapeutics (NASDAQ:TENX - Free Report) in a research note issued to investors on Monday. The firm issued a sell rating on the specialty...\n more…

Tenax Therapeutics (NASDAQ:TENX) Earns Sell Rating from Analysts at StockNews.com
Tenax Therapeutics (NASDAQ:TENX) Earns Sell Rating from Analysts at StockNews.com

Ticker Report StockNews.com initiated coverage on shares of Tenax Therapeutics (NASDAQ:TENX - Free Report) in a report published on Monday. The firm issued a sell rating on the specialty pharmaceutical company's...\n more…

Tenax Therapeutics (NASDAQ:TENX) Earns Sell Rating from Analysts at StockNews.com
Tenax Therapeutics (NASDAQ:TENX) Earns Sell Rating from Analysts at StockNews.com

Ticker Report Analysts at StockNews.com initiated coverage on shares of Tenax Therapeutics (NASDAQ:TENX - Get Free Report) in a research note issued on Sunday. The brokerage set a "sell" rating on the specialty...\n more…